AFT Pharmaceuticals Limited

NZSE AFT.NZ

AFT Pharmaceuticals Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD -6.36 M

AFT Pharmaceuticals Limited Net Cash Used Provided By Financing Activities is USD -6.36 M for the year ending March 31, 2024, a -45.68% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • AFT Pharmaceuticals Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD -4.36 M, a -60.82% change year over year.
  • AFT Pharmaceuticals Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD -2.71 M, a -254.03% change year over year.
  • AFT Pharmaceuticals Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD 1.76 M, a 132.41% change year over year.
  • AFT Pharmaceuticals Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD -5.43 M, a -314.52% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
NZSE: AFT.NZ

AFT Pharmaceuticals Limited

CEO Dr. Hartley Atkinson Ph.D.
IPO Date Dec. 21, 2015
Location New Zealand
Headquarters 129 Hurstmere Road
Employees 110
Sector Health Care
Industries
Pharmaceuticals
Description

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

StockViz Staff

January 15, 2025

Any question? Send us an email